Module Name Pharmacotherapy 3
Module level, if applicable 3rd Year
Code, if applicable SFA-656
Semester (s) in which the module is taught Sixth Semester
Person responsible for the module apt. Chynthia Pradiftha Sari, M.Sc
Lecturer(s) apt. Chynthia Pradiftha Sari, M.Sc

apt. Suci Hanifah, MSc., PhD

Language Bahasa Indonesia
Relation to curriculum Compulsory course 
Types of teaching and learning Class size Attendance time (hours per week per semester) Forms of active participation Workload
Lecture 50 2 Discussion Lecture: 2 (hour) x 14 (meeting) 28
Preparation and follow up 4 (hour) x 14 (self-learning)

 

56
Case based Learning 50 1 Report Attendance time 1 (hour) x 12 (meeting)  12
Preparation and follow up 4 (hour) x 14 (self-learning) 24
Total workload 120 hours
ECTS 4.29 ECTS
Credit points 3 CU
Requirements according to examination regulations Minimum attendance at lectures is 75% (according to UII regulation). Final score is evaluated based on assignment and reports (40%), mid semester exam (30%), and end semester exam (30%).   
Recommended prerequisites Pharmacology
Related course
Module objectives/intended learning On successful completion of the course students will be able to assess and evaluate a pharmacotherapy from the patient with gastrointestinal disorder, ophthalmic disorder, and respiratory disorder. 
Content The course covers the pathophysiology, therapeutic management (pharmacological and non-pharmacological) and pharmacy practice issues in the management of patients with a range of disorders including:

  1. Constipation
  2. Diarrhea 
  3. Peptic ulcer disease
  4. Nausea and vomiting 
  5.  Hepatitis
  6. Cirrhosis 
  7. Rhinitis
  8. Asthma
  9. Chronic Obstructive Pulmonary Disease
  10. Glaucoma 
Study and examination requirements and forms of examination Mid-term, Final term, assignments
Media employed Textbooks, slides (power points), video, Google classroom
Reading lists
  1. Brunton, L., Chabner B., Knoliman B, 2011, Godman and Gilman’s The Pharmacological Basis of Therapeutics, McGraw-Hill
  2. Dipiro, JT., Talbert, RL., Yee., et al., 2017, Pharmacotherapy; a pathophysiologic approach, 10th ed, McGrawn-Hill
  3. GINA (Global Initiative for Asthma)
  4. GOLD (Global Initiative for Chronic Obstructive Lung Disease)
  5. www.cochrane.org 
  6. www.nejm.com 
  7. www.bmj.com